Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASA vs rivaroxaban after Fontan operation
IRCT20250814066855N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rivaroxaban and aspirin in Cardiovascular Malformation (CVM) (2 arms), sponsored by Isfahan University of Medical Sciences. Started Sep 2025; status: completed.
02
Drugs
rivaroxabanaspirin
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on IRCT20250814066855N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250814066855N1.